²é¿´: 1374  |  »Ø¸´: 1

fuanxitan

Ìú³æ (СÓÐÃûÆø)

[½»Á÷] BioTechniques£º2015×îÊÜ»¶Ó­µÄ¼¼ÊõÎÄÕ ÒÑÓÐ1È˲ÎÓë

1. Visual detection of isothermal nucleic acid amplification using pH-sensitive dyes

ÎÒÃǶ¼ÔøÔÚ»¯Ñ§¿ÎÉϸù¾ÝpHÊÔÖ½µÄÑÕÉ«ÅжϹýÈÜÒºµÄËá¼î¶È¡£NEB¹«Ë¾µÄÑо¿ÍŶÓÒÔͬÑùµÄÀíÄ»ùÓÚpHÖµµÄÑÕÉ«¸Ä±ä£©Îª»ù´¡£¬¿ª·¢ÁËÒ»ÖÖ¶ÔpHÃô¸ÐµÄ±äɫȾÁÏ£¬¸øDNAÀ©Ôö¸³ÓèÁËÈâÑۿɼûµÄÑÕÉ«¸Ä±ä¡£ÕâÒ»¼¼Êõ¿ÉÒÔ°ïÖúÈËÃÇÖ±½ÓÓÃÑÛ¾¦ÅжϺËËáÀ©ÔöµÄ½á¹û£¬²»ÐèÒª½èÖúÈκÎÌØÊâÉ豸£¬ÔÚÒ°ÍâÑо¿¡¢Ìï¼äÊÔÑé¡¢ÁÙ´²Õï¶ÏµÈÁìÓòÓÐ׏ãÀ«µÄÓ¦ÓÃǰ¾°¡£

2. A single protocol for extraction of gDNA from bacteria and yeast

Ðí¶à·Ö×ÓÉúÎïѧ¼¼Êõ¶¼ÔÚ±»ÈËÃDz»¶ÏÓÅ»¯£¬±ÈÈçPCR¡¢ÖÊÆ×ºÍ²âÐò¡£È»¶ø£¬DNAÌáÈ¡·½·¨È´Ê¼ÖÕûÓÐʲô̫´óµÄ¸Ä±ä¡£

ÕâÏîÑо¿ÎªÈËÃÇչʾÁËÒ»ÖÖеÄDNAÌáÈ¡·½·¨¡£Ñо¿ÏÔʾ£¬¼ÓÈÈÒÒ´¼¼îÐÔÈÜÒº£¬ÄÜÒÔÏàËÆµÄЧÂÊÊͷųöϸ¾úºÍ½ÍĸÖеĵ¥Á´DNA¡£ÀëÐÄËùµÃµÄDNA¿ÉÒÔÖ±½ÓʹÓã¬Ò²¿ÉÒÔÌí¼Óµ½¹è½ºÖù½øÒ»²½´¿»¯¡£ÕâÖÖ¿ìËÙ¡¢¾­¼Ã¶øÇÒ¿É¿¿µÄ·½·¨ÓÐÖúÓÚ¼ø¶¨Î´ÖªµÄ΢ÉúÎËü²»»áºöÊÓ»òÆ«ÏòÌØ¶¨Î¢ÉúÎï¡£ÕâÖÖDNAÌáÈ¡·½·¨ÄÜÔÚ25·ÖÖÓÄÚ´¦Àí¸÷ÖÖÉúÎïÑùÆ·£¬¿ÉÒÔÓÃÓÚÁÙ´²Õï¶Ï»òÕßÉúÎïҽѧÑо¿¡££¨Ïà¹Ø±¨µÀ£ºBioTechniques£º´Óϸ¾úºÍ½ÍĸÖÐÌáÈ¡gDNAµÄ¼ò±ã·½·¨£©

3. Affinity proteomics to study endogenous protein complexes: Pointers, pitfalls, preferences and perspectives

µ°°×³£³£Í¨¹ýÏ໥×÷ÓÃÀ´Ö´ÐÐϸ°û¹¦ÄÜ£¬ÌØÒìÐÔ·ÖÀëµ°°×¼°Æä»¥×÷´îµµ£¬¶ÔÓÚ½âÎöϸ°ûÌåϵºÜÓаïÖú¡£Ç׺Ͳ¶»ñ¼¼ÊõÀûÓøßÇ׺ÍÁ¦¡¢¸ßÌØÒìÐÔµÄÊÔ¼Á£¬ÔÚϸ°ûÌáÈ¡ÎïÖв¶×½Ä¿µÄµ°°×¼°ÆäÏà¹Øµ°°×¡£½«Ç׺Ͳ¶»ñÓëÖÊÆ×½áºÏÆðÀ´½øÐе°°×ÖÊ×é·ÖÎö£¬¿ÉÒÔ·ÖÀëºÍ¼ø¶¨´óÁ¿µÄÄÚÔ´ÐÔµ°°×¸´ºÏÌå¡£ÕâÆªÎÄÕ²ûÊöÁËÇ׺Ͳ¶»ñµ°°×¸´ºÏÌåµÄÓÐЧ²½Ö裬̽ÌÖÁ˽øÐÐÕâÀàʵÑéµÄ×î¼Ñ·½·¨ºÍһЩ³£¼ûÎóÇø¡£

4. CRISPR/Cas9 nuclease cleavage combined with Gibson assembly for seamless cloning

CRISPR-Cas9ÊÇϸ¾úÔÚÂþ³¤µÄ½ø»¯Ê·ÖÐÑÝ»¯³öµÄÖØÒª·ÀÓù»úÖÆ¡£Õâ¸ö¼à¿ØÌåϵÄܹ»¸ù¾ÝÒýµ¼RNAµÄָʾ£¬°Ð±ê²¢½µ½âÈëÇÖÕßµÄÒÅ´«ÎïÖÊ¡£ÏÖÔÚ£¬CRISPR-Cas9ÒѾ­³ÉΪÁËÖËÊÖ¿ÉÈȵĻùÒò×é±à¼­¹¤¾ß£¬°ïÖúÊÀ½ç¸÷µØµÄÑо¿ÕßÃǽâ¾öʵ¼ÊÎÊÌâ¡£

¿Ë¡ÊÇ»ùÒò¹¤³ÌµÄÒ»¸ö»ù±¾¹¤¾ß£¬ÕâÏîÑо¿½«CRISPR¨CCas9ÓëGibson assembly½áºÏÆðÀ´£¬¿ª·¢ÁËÒ»ÖÖ¿ìËÙÓÐЧµÄÎÞ·ì¿Ë¡¼¼Êõ¡£Ñо¿ÈËԱʹÓÃÒ»¸öT7ת¼ģ°åÀ´Éú³ÉÒýµ¼RNA£¨sgRNA£©£¬°Ð±ê¿ËÂ¡ÔØÌåÉϵÄÌØ¶¨Î»µã¡£ËûÃÇÓÃÕâÖÖsgRNAºÍCas9ÇпªÁËÒ»¸ö22 kbµÄÔØÌ壬²¢Í¨¹ýGibson assemblyÔÚÆäÖвåÈëÒ»¶ÎDNA¡£Ñо¿±íÃ÷£¬ÕâÊÇÒ»¸öÄܹ»ÊµÏÖÎÞ·ì¿Ë¡µÄÇ¿´ó¹¤¾ß£¬¿É½«DNAƬ¶ÎÖ±½Ó²åÈëÔØÌåÉϵİÐλµã¡£

5. Preparation of amino acid mixtures for cell-free expression systems

ÕâÆªÎÄÕÂÃèÊöÁËÒ»¸öΪÎÞϸ°ûµ°°×±í´ïÌåÏµÖÆ±¸¸ßŨ¶È°±»ùËá»ìºÏÎïµÄÓÐЧ·½·¨¡£Ñо¿ÈËԱͨ¹ýÕâÒ»·½·¨»ñµÃÁËÀíÏëµÄ°±»ùËá×é³ÉºÍÉúÀíÐÔpH¡£ÕâÖÖ·½·¨Ëٶȿ죬ÈÝÒײÙ×÷£¬Ò²±ÈÉÌÒµ»¯ÊÔ¼ÁºÐ±ãÒË¡£ÈËÃÇ¿ÉÒÔÔÚ´Ë»ù´¡ÉϽøÐиßͨÁ¿ÊµÑé¡¢ÎÞϸ°û´úл¹¤³Ì»òÕß²ôÈë·Ç±ê×¼°±»ùËá¡£

6. Micropatterning strategies to engineer controlled cell and tissue architecture in vitro

΢ͼ°¸»¯¼¼Êõ£¨Micropatterning£©¿ÉÔÚÌåÍâ¿ØÖÆÏ¸°ûºÍ×éÖ¯µÄ¹¹¼Ü£¬ÊÇÄ£Äâ×é֯΢»·¾³µÄʵÓÃÆ½Ì¨¡£ÕâÆª×ÛÊöÎÄÕ½éÉÜÁËһЩ³£ÓõÄ΢ͼ°¸»¯¼¼Êõ£¬¿ÉÒÔÒýµ¼ÐÂÊÖÕÒµ½ÊʺÏ×Ô¼ºµÄ·½·¨£¬°ïÖúËûÃÇ»ñµÃ×Ô¼ºÏëÒªµÄ×é֯ģʽ¡£ÎÄÕ»¹Ì½ÌÖÁË΢ͼ°¸»¯¼¼ÊõĿǰËùÃæÁÙµÄһЩ¹Ø¼üÐÔÌôÕ½¡£

7. Simultaneous isolation of enriched myoblasts and fibroblasts for migration analysis within a novel co-culture assay

ÕâÒ»¼¼Êõ¿ÉÒÔ°ïÖúÈËÃÇÔÚ½ºÔ­Ã¸Ïû»¯Ö®ºó£¬Í¬Ê±·ÖÀëºÍ¸»¼¯³ÉÏËάϸ°ûºÍ³É¼¡Ï¸°û¡£ÕâЩϸ°ûËæºó¿ÉÓÃÓÚÒ»¸ö¹²ÅàÑøµÄ´´ÉËÐÞ¸´ÏµÍ³£¬ÎªÈËÃǽÒʾ³ÉÏËάϸ°û¶Ô³É¼¡Ï¸°ûÇ¨ÒÆµÄÓ°Ïì¡£

8. High-throughput detection of DNA double-strand breaks using image cytometry

ÕâÏîÑо¿ÎªÈËÃÇչʾÁËÒ»¸ö¸ßͨÁ¿µÄ·½·¨£¬ÓÃͼÏñϸ°û·ÖÎö¼¼Êõ£¨image cytometry£©¿Í¹ÛµØÑо¿DNAË«Á´¶ÏÁѵÄϸ°ûÐÞ¸´»úÖÆ¡£

9. Abridged adapter primers increase the target scope of Hi-Plex

Hi-PlexÊÇÒ»ÖÖÒÔÀ©Ôö×ÓΪ»ù´¡µÄ°ÐÏòÐÔ´ó¹æÄ£Æ½ÐвâÐò¼¼Êõ¡£Ñо¿ÈËÔ±¶ÔHi-Plex·½·¨½øÐÐÁ˸ÄÁ¼£¬Ê¹Æä¿ÉÒ԰бê¸ü¶àµÄÀ©Ôö×Ó£¨16¨C1003£©¡£ËûÃÇ»¹Óýض̵ĽÓÍ·ÒýÎïÀ´Ìæ´úÈ«³¤µÄ½ÓÍ·ÒýÎ³É¹¦¼õÉÙÁË֮ǰµÄÍѰÐЧӦ¡£

10. Introduction of the hybcell-based compact sequencing technology and comparison to state-of-the-art methodologies for KRAS mutation detection

ÕâÏîÑо¿½«»ùÓÚhybcellµÄ²âÐò¼¼ÊõÓÃÓÚKRASÍ»±ä·ÖÎö£¬²¢½«ÕâÖÖ·½·¨ÓëSanger²âÐò¡¢½¹Á×Ëá²âÐòºÍ¶þ´ú²âÐò½øÐÐÁ˱Ƚϡ£Ñо¿Ö¸³ö£¬ÒÔhybcellΪ»ù´¡µÄ²âÐò¼¼ÊõºÜÊʺÏÔÚÖ×ÁöÑù±¾Öмì²âKRASµãÍ»±ä¡£
»Ø¸´´ËÂ¥

» ²ÂÄãϲ»¶

» ±¾Ö÷ÌâÏà¹ØÉ̼ÒÍÆ¼ö: (ÎÒÒ²ÒªÔÚÕâÀïÍÆ¹ã)

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

liu_yanpeng

Ìú¸Ëľ³æ (СÓÐÃûÆø)

¡ï
Сľ³æ: ½ð±Ò+0.5, ¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
ÇëÎÊÏà¹ØÎÄÕÂÔÚÄÄ
2Â¥2016-01-29 13:30:12
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ fuanxitan µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] ×Ü·Ö293Çóµ÷¼Á +4 ¼ÓÒ»Ò»¾Å 2026-03-25 4/200 2026-03-25 12:56 by Dyhoer
[¿¼ÑÐ] 284Çóµ÷¼Á +15 Zhao anqi 2026-03-22 15/750 2026-03-25 12:51 by wht0531
[¿¼ÑÐ] 359Çóµ÷¼Á +3 ÍõÁ˸öéª 2026-03-25 3/150 2026-03-25 12:50 by Dyhoer
[¿¼ÑÐ] 274Çóµ÷¼Á +6 ¹Ë¾ÅóÏҪǫÐé 2026-03-24 6/300 2026-03-25 11:51 by userper
[¿¼ÑÐ] Ò»Ö¾Ô¸¼ªÁÖ´óѧ²ÄÁÏÓ뻯¹¤303·ÖÇóµ÷¼Á +4 Ϊѧ666 2026-03-24 4/200 2026-03-25 11:27 by BruceLiu320
[¿¼ÑÐ] 292Çóµ÷¼Á +4 ¶ì¶ì¶ì¶î¶î¶î¶î¶ 2026-03-25 4/200 2026-03-25 10:37 by barlinike
[¿¼ÑÐ] 0854µç×ÓÐÅÏ¢Çóµ÷¼Á +7 ¦Á____ 2026-03-22 8/400 2026-03-25 08:02 by ààgkvc
[¿¼ÑÐ] ²ÄÁÏѧÇóµ÷¼Á +6 Stella_Yao 2026-03-20 6/300 2026-03-25 00:37 by baoball
[¿¼ÑÐ] 08¹¤Ñ§µ÷¼Á +12 Óû§573181 2026-03-20 17/850 2026-03-24 21:45 by ·¬ÇÑìÀÁËÎ÷ºìÊÁ
[¿¼ÑÐ] 276Çóµ÷¼Á¡£ÓаëÄêµç³ØºÍ°ëÄê¸ß·Ö×Óʵϰ¾­Àú +9 ²ÄÁÏѧ257Çóµ÷¼Á 2026-03-23 10/500 2026-03-24 07:36 by wangy0907
[¿¼ÑÐ] Çóµ÷¼Á +7 Ê®Èý¼ÓÓÍ 2026-03-21 7/350 2026-03-23 23:48 by ÈÈÇéɳĮ
[¿¼ÑÐ] 335·Ö | ²ÄÁÏÓ뻯¹¤×¨Ë¶ | GPA 4.07 | ÓпÆÑо­Àú +4 cccchenso 2026-03-23 4/200 2026-03-23 23:00 by Ðìckkk
[¿¼ÑÐ] 384Çóµ÷¼Á +3 ×Óϵ²© 2026-03-22 6/300 2026-03-23 21:45 by ×Óϵ²©
[¿¼ÑÐ] 328Çóµ÷¼Á +4 LHHL66 2026-03-23 4/200 2026-03-23 14:55 by lbsjt
[¿¼ÑÐ] Ò»Ö¾Ô¸070300Õã´ó»¯Ñ§358·Ö£¬Çóµ÷¼Á£¡ +4 ËÖËÖÓã.. 2026-03-21 4/200 2026-03-23 08:12 by Iveryant
[¿¼ÑÐ] ²ÄÁÏÓ뻯¹¤085600£¬×Ü·Ö304£¬±¾¿ÆÓÐÁ½Æªsci²ÎÓ룬Çóµ÷¼Á +4 ÐÒÔ˵Ľ´½´ 2026-03-22 5/250 2026-03-22 20:15 by edmund7
[¿¼ÑÐ] ÉúÎïѧµ÷¼Á +5 Surekei 2026-03-21 5/250 2026-03-22 14:39 by tcx007
[¿¼ÑÐ] Çóµ÷¼Á +7 Auroracx 2026-03-22 7/350 2026-03-22 12:38 by ËØÑÕÇã³Ç1988
[¿¼ÑÐ] Ò»Ö¾Ô¸ÄÏÀí¹¤085701»·¾³302Çóµ÷¼ÁԺУ +3 ¿ûè÷ÎÀ¶Ó 2026-03-20 3/150 2026-03-20 19:28 by zhukairuo
[¿¼ÑÐ] 0856µ÷¼Á£¬ÊÇѧУ¾ÍÈ¥ +8 sllhht 2026-03-19 9/450 2026-03-20 14:25 by ÎÞи¿É»÷111
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û